Sorrento Therapeutics Inc (SRNE)

Get the latest Sorrento Therapeutics Inc (SRNE) share price, news, and insights for smarter trading. Stay informed with FP Markets .

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Sorrento Therapeutics Inc (SRNE) Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody-drug conjugates. It operates through Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

Sorrento Therapeutics, Inc. has 502 total employees across all of its locations and generates $39.99 m.illion in sales (USD Market Cap1.501B USD Stock price: SRNE (NASDAQ) $4.90 +0.03 (+0.62%) Sorrento Therapeutics Inc (SRNE.xnas )News On Monday, the company said that initial lab testing of COVISTIX - the company’s Covid-19 rapid antigen detection test - showed that in addition to being able to detect the original SARS-CoV-2 virus and other significant variants of concern (VOCs) including the Delta and Delta-plus strains, the test can identify the Omicron variant. Not only that, but the lab results show that it could detect the Omicron N protein at a much lower level than other Emergency Use Authorization (EUA) approved commercially-available tests.

Sorrento Therapeutics Inc (SRNE.xnas) Analysis Sorrento Therapeutics (SRNE) might not receive widespread coverage on Wall Street, but one analyst has repeatedly banged the drum for the drugmaker.

H.C. Wainwright’s Ram Selvaraju thinks SRNE stocks are significantly undervalued. Backing his Buy rating with a $26 price target, the analyst sees stocks climbing ~430% in the year ahead. Subsidiaries; ACEA Therapeutics, SILEX pharmaceuticals, bioserv, Smart Pharm Therapeutics, ark animal health,

Start Trading Sorrento Therapeutics Inc (SRNE) with a Market Leader Today

Sorrento Therapeutics Inc (SRNE) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram